New Weight-Loss pill ZT006 enters Mid-Stage trial

NCT ID NCT07230132

Ongoing Disease control Sponsor: Beijing QL Biopharmaceutical Co.,Ltd Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This Phase 2 study tests whether ZT006, a daily or weekly tablet, helps overweight and obese adults lose weight when combined with diet and exercise. About 184 participants will receive either ZT006 or a placebo for 28 weeks, with some continuing for an extra 12 weeks. The main goal is to measure weight change and check for side effects.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: ZT006
What this could lead to: If successful, this could lead to a new weight-loss medication for overweight and obese individuals.
What could go wrong: This is an early Phase 2 trial with only 184 participants, so results may not apply to everyone. The drug may cause side effects or fail to show significant weight loss compared to placebo.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for OVERWEIGHT , OBESITY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Obesity obesity disorder Overweight

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

OVERWEIGHT , OBESITY

Contacts and locations

Locations

Central Hospital Affiliated to Shandong First Medical University

Jinan, Shandong, 250000, China
First Hospital of Shanxi Medical University

Taiyuan, Shanxi, 030001, China
Handan First Hospital

Handan, Hebei, 056002, China
Harbin Medical University Affiliated Fourth Hospital

Harbin, Heilongjiang, 150001, China
Hebei Petro China Central Hospital

Langfang, Hebei, 065000, China
Huzhou Central Hospital

Huzhou, Zhejiang, China
Luoyang Third People's Hospital

Luoyang, Henan, 471002, China
Peking University People's Hospital

Beijing, 100044, China
The First People's Hospital of Chenzhou

Chenzhou, Hunan, China
The Second Affiliated Hospital of Nanjing Medical University

Nanjing, Jiangsu, 210003, China
Xi'an Daxing Hospital

Xi’an, Shanxi, 710000, China
YueYang People's Hospital

Yueyang, Hunan, 414022, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.